Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...
August 13 2019 - 5:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
25
NOTIFICATION OF REMOVAL FROM LISTING
AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-37604
OASMIA PHARMACEUTICAL AB
NASDAQ Capital Markets
(Exact name of Issuer as specified in its
charter, and name of Exchange
where security is listed and/or registered)
Vallongatan 1
752 28 Uppsala, Sweden
+46 18 50 54 40
(Address, including zip code, and
telephone number, including area code, of Issuer’s principal executive offices)
American Depositary Shares, each representing
three (3) Ordinary Shares, par value SEK 0.10 per share
Ordinary Shares, par value SEK 0.10 per
share
(Description of class of securities)
Please place an X in the box to designate the rule provision
relied upon to strike the class of securities from listing and registration:
¨
|
17 CFR 240.12d2-2(a)(1)
|
¨
|
17 CFR 240.12d2-2(a)(2)
|
¨
|
17 CFR 240.12d2-2(a)(3)
|
¨
|
17 CFR 240.12d2-2(a)(4)
|
¨
|
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
|
x
|
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
Pursuant to the requirements of the Securities Exchange Act
of 1934, Oasmia Pharmaceutical AB certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
August 12, 2019
|
|
|
|
By
|
|
/s/ Jörgen Olsson
|
|
|
|
Chairman of the Board
|
Date
|
|
|
|
|
|
Name
|
|
|
|
Title
|
***
Oasmia Pharmaceuticals AB (NASDAQ:OASM)
Historical Stock Chart
From May 2024 to Jun 2024
Oasmia Pharmaceuticals AB (NASDAQ:OASM)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Oasmia Pharmaceuticals AB (NASDAQ): 0 recent articles
More Oasmia Pharmaceutical Ab News Articles